Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Kinetics of HER2/neu ECD in 45 Patients Treated with Trastuzumab (Herceptin®) between January 2001 and June 2005 at the Grenoble University Hospital

ANNE-SOPHIE GAUCHEZ, MARC COLONNA, FRANÇOIS-XAVIER BRAND, NADIA RAVANEL, DOMINIQUE PASQUIER, RAOUL PAYAN and MIREILLE MOUSSEAU
Anticancer Research May 2009, 29 (5) 1703-1707;
ANNE-SOPHIE GAUCHEZ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ASGauchez{at}chu-grenoble.fr
MARC COLONNA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FRANÇOIS-XAVIER BRAND
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NADIA RAVANEL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOMINIQUE PASQUIER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RAOUL PAYAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MIREILLE MOUSSEAU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Dynamics of HER2/neu ECD serum concentrations in patients treated with Herceptin®.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Survival curves according to HER2/neu ECD serum kinetic profiles.

Tables

  • Figures
  • Table I.
  • Table II.
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 29, Issue 5
May 2009
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
  • Back Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Kinetics of HER2/neu ECD in 45 Patients Treated with Trastuzumab (Herceptin®) between January 2001 and June 2005 at the Grenoble University Hospital
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
16 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Kinetics of HER2/neu ECD in 45 Patients Treated with Trastuzumab (Herceptin®) between January 2001 and June 2005 at the Grenoble University Hospital
ANNE-SOPHIE GAUCHEZ, MARC COLONNA, FRANÇOIS-XAVIER BRAND, NADIA RAVANEL, DOMINIQUE PASQUIER, RAOUL PAYAN, MIREILLE MOUSSEAU
Anticancer Research May 2009, 29 (5) 1703-1707;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Kinetics of HER2/neu ECD in 45 Patients Treated with Trastuzumab (Herceptin®) between January 2001 and June 2005 at the Grenoble University Hospital
ANNE-SOPHIE GAUCHEZ, MARC COLONNA, FRANÇOIS-XAVIER BRAND, NADIA RAVANEL, DOMINIQUE PASQUIER, RAOUL PAYAN, MIREILLE MOUSSEAU
Anticancer Research May 2009, 29 (5) 1703-1707;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • A Reminder App for Optimizing Bladder Filling During Radiotherapy for Prostate Cancer: A Pre-study in Healthy Volunteers
  • Timing and Risk Factors for Hyperglycemia Associated With Anamorelin Administration
  • Identification of Risk Factors for the Local Recurrence of Hepatocellular Carcinoma Post-radiofrequency Ablation
Show more Clinical Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire